IRTC250117P45000
- 1.25
- 0.000.00%
iRhythm Technologies Newsroom
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $111
Insiders At IRhythm Technologies Sold US$8.0m In Stock, Alluding To Potential Weakness
Goldman Sachs Maintains IRhythm Technologies(IRTC.US) With Hold Rating, Raises Target Price to $91
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $95
Strategic Growth and Expansion of Irhythm Technologies: A Promising Future in Arrhythmia Detection
J.P. Morgan Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $97
IRhythm Technologies Is Maintained at Buy by Canaccord Genuity
CCORF Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $152
Express News | IRhythm Technologies Inc : Canaccord Genuity Raises Target Price to $152 From $125
Insider Sale: CBO and CLO of $IRTC (IRTC) Sells 2,492 Shares
IRhythm Technologies Price Target Announced at $86.00/Share by Wells Fargo
IRhythm Technologies Analyst Ratings
Hold Rating on Irhythm Technologies Amid Regulatory Uncertainties and Growth Challenges
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Does IRhythm Technologies (NASDAQ:IRTC) Have A Healthy Balance Sheet?
DexCom Pairs Its Glucose Monitor With Oura's Smart Ring -- Barrons.com
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $85
IRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
Insider Purchase: Director at Irhythm Technologies (IRTC) Buys 6,664 Shares